 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 查看: 2289 | 回復: 11 | |||||
[交流]
GSK被調查，會對醫(yī)藥行業(yè)各個產業(yè)鏈產生什么影響 已有11人參與
|
|||||
| 大家都來深入淺出的分析一下 |
回復此樓» 收錄本帖的淘帖專輯推薦
 新藥研發(fā)必備資料 | 行業(yè)動態(tài) |
» 猜你喜歡
腦梗怎么治療
已經有3人回復
-
腦梗怎么治療
已經有0人回復
-
藥理學論文潤色/翻譯怎么收費?
已經有272人回復
-
生物組織中有目標分析物，專屬性怎么做
已經有0人回復
-
【招聘】清華大學藥學院錢鋒教授課題組誠聘博士后
已經有1人回復
-
新版scifinder
已經有1人回復
-
安捷倫液相色譜柱與方法開發(fā)指南
已經有4人回復
-
2026申請考核博士自薦-蛋白質組學/AI/藥物設計/AIDD/化學生物學
已經有1人回復
-
中國醫(yī)藥行業(yè)發(fā)展現(xiàn)狀：標準品推動藥品檢測水平提升
已經有1人回復
» 本主題相關商家推薦: (我也要在這里推廣)
buffalo2012
銀蟲 (小有名氣)
- 應助: 0 (幼兒園)
- 金幣: 1957.5
- 帖子: 61
- 在線: 73.8小時
- 蟲號: 1636297
- 注冊: 2012-02-23
- 專業(yè): 細胞信號轉導
★
小木蟲: 金幣+0.5, 給個紅包，謝謝回帖
小木蟲: 金幣+0.5, 給個紅包，謝謝回帖
|
柳葉刀文章，轉自丁香園，分析GSK事件，說中國醫(yī)患問題可能與醫(yī)生和某些藥企的不健康關系有關，請看下文： Doctors and pharma in China The Lancet Doctor—patient relationships in China are in crisis. Doctors have been injured or even killed by patients at work. One of the major drivers might be the unhealthy and unethical relations between many doctors and some drug companies. On July 8, GlaxoSmithKline (GSK) said that they were investigating allegations that its staff had improperly used cash and other incentives to encourage the prescription of onabotulinumtoxin A (Botox) in China. The company added that “inquiries to date have found no evidence of bribery or corruption in relation to our sales and marketing of therapeutic Botox in China.” The Lancet has no evidence to suggest that the allegations against GSK in China are true. However, some observers claim that bribing doctors to boost drug prescriptions by some drug companies is an open secret, and that this alleged practice has compromised the public's trust in doctors. The varieties of unethical relationships that exist between some doctors and some of the drug companies in China are said to range from cash kickbacks, lavish gifts or entertainment, ghost writing services, sponsored supplements in journals, and all-expenses-paid trips. There is real concern that doctors' prescriptions are therefore not based solely on patient need and clinical evidence, but may be biased by commercial interests. The perceived unethical association between physicians and industry in China is worrying, because it inevitably harms patients as well as doctors. It damages the doctor—patient relationship and, ultimately, China's whole health system. The GSK China allegations, although unproven, have clearly rung an alarm bell for China's regulatory authorities to ensure the drug industry promotes products in a responsible, ethical, and professional way. Chinese doctors should rely on evidence-based clinical guidelines to inform their practice, and are in urgent need of guidance on their collaborations with the drug industry in various areas such as patient care, professional education, and research. Furthermore, training for doctors in China on managing their relationships ethically with the drug industry and other organisations should start at medical school and be part of continuing professional education. |
3樓2013-07-17 14:31:18
cydwood
金蟲 (小有名氣)
- 應助: 3 (幼兒園)
- 金幣: 1146
- 帖子: 164
- 在線: 100.3小時
- 蟲號: 536376
- 注冊: 2008-03-30
- 性別: GG
- 專業(yè): 有機合成
2樓2013-07-17 13:17:45
先是網上報紙上罵聲一片，然后磚家出來澄清，然后。。。。。就沒有然后了。 4樓2013-07-17 14:33:25
5樓2013-07-17 19:26:08
baijiazi
至尊木蟲 (著名寫手)
- 應助: 6 (幼兒園)
- 金幣: 13598.4
- 紅花: 3
- 帖子: 2257
- 在線: 1388.6小時
- 蟲號: 1067163
- 注冊: 2010-07-31
- 性別: GG
- 專業(yè): 無機材料化學
6樓2013-07-17 21:58:30
cpuyou
鐵桿木蟲 (職業(yè)作家)
圣行者
- 應助: 82 (初中生)
- 金幣: 9903.5
- 紅花: 19
- 帖子: 3698
- 在線: 815.7小時
- 蟲號: 840835
- 注冊: 2009-09-05
- 性別: GG
- 專業(yè): 藥劑學
7樓2013-07-18 16:32:40
shenwuyan
鐵蟲 (初入文壇)
- 應助: 2 (幼兒園)
- 金幣: 49
- 帖子: 45
- 在線: 10.3小時
- 蟲號: 1079603
- 注冊: 2010-08-22
- 性別: GG
- 專業(yè): 免疫學研究新技術與新方法
8樓2013-07-18 16:56:13
9樓2013-07-18 17:44:16
jason2050
木蟲 (小有名氣)
- 應助: 1 (幼兒園)
- 金幣: 2461
- 帖子: 138
- 在線: 161.1小時
- 蟲號: 1748817
- 注冊: 2012-04-10
- 性別: GG
- 專業(yè): 消化道動力異常及功能性胃
10樓2013-07-19 09:11:32
相關版塊跳轉
我要訂閱樓主 冥思苦想 的主題更新
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 材料080500調劑求收留 +7 | 一顆meteor 2026-03-13 | 7/350 |
|
|---|---|---|---|---|
|
[考研] 281求調劑（0805） +14 | 煙汐憶海 2026-03-16 | 25/1250 |
|
|
|
[考研] 265求調劑 +8 | 梁梁校校 2026-03-17 | 8/400 |
|
|
|
[考研] 279分求調劑 一志愿211 +9 | chaojifeixia 2026-03-19 | 10/500 |
|
|
|
[考研] 招收調劑碩士 +4 | lidianxing 2026-03-19 | 12/600 |
|
|
|
[論文投稿]
申請回稿延期一個月，編輯同意了。但系統(tǒng)上的時間沒變，給編輯又寫郵件了，沒回復
 10+3
|
wangf9518 2026-03-17 | 4/200 |
|
|
|
[考研] 0703化學調劑 +10 | 妮妮ninicgb 2026-03-15 | 14/700 |
|
|
|
[考研] 294求調劑材料與化工專碩 +14 | 陌の森林 2026-03-18 | 14/700 |
|
|
|
[考研] 復試調劑 +4 | z1z2z3879 2026-03-14 | 6/300 |
|
|
|
[考研] 一志愿西安交通大學材料工程專業(yè) 282分求調劑 +5 | 楓橋ZL 2026-03-18 | 7/350 |
|
|
|
[考研] 材料與化工求調劑 +7 | 為學666 2026-03-16 | 7/350 |
|
|
|
[考研] 346求調劑[0856] +3 | WayneLim327 2026-03-16 | 6/300 |
|
|
|
[考研] 0817調劑 +3 | 沒有答案_ 2026-03-14 | 3/150 |
|
|
|
[考研] 344求調劑 +6 | knight344 2026-03-16 | 7/350 |
|
|
|
[考研] 334求調劑 +3 | 志存高遠意在機?/a> 2026-03-16 | 3/150 |
|
|
|
[考研] 一志愿蘇州大學材料工程（085601）專碩有科研經歷三項國獎兩個實用型專利一項省級立項 +6 | 大火山小火山 2026-03-16 | 8/400 |
|
|
|
[考研] 藥學383 求調劑 +3 | 藥學chy 2026-03-15 | 4/200 |
|
|
|
[考研] 機械專碩325，尋找調劑院校 +3 | y9999 2026-03-15 | 5/250 |
|
|
|
[考研] 26考研一志愿中國石油大學(華東)305分求調劑 +3 | 嘉年新程 2026-03-15 | 3/150 |
|
|
|
[考研] 本科南京大學一志愿川大藥學327 +3 | 麥田耕者 2026-03-14 | 3/150 |
|